Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma
- PMID: 21875430
- PMCID: PMC8369833
- DOI: 10.1111/j.1440-1746.2011.06891.x
Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma
Abstract
Background and aim: Hepatocellular carcinoma (HCC) is the third most common reason for cancer-related death worldwide. Many countries either lack appropriate clinical practice guidelines for the diagnosis and treatment of HCC or the quality of their guidelines has never been evaluated. The main objective of our work was to identify published HCC guidelines and assess their quality with the Appraisal of Guidelines for Research and Evaluation instrument (AGREE) and their suitability regarding adaptation for future guidelines.
Methods: We performed a systematic literature search on HCC clinical practice guidelines of MEDLINE, National Guidelines Clearinghouse and the Guidelines International Network. Methodological quality of selected guidelines was assessed by the AGREE instrument, Version 2001.
Results: A total of 286 citations were screened and 32 relevant guidelines were identified. Overall, the guidelines performed well in the clarity and presentation domain with a mean score of 67%, followed by scope and purpose (55%) and rigor of development (50%). In contrast, poor scores were given for the remaining domains: stakeholder involvement (23%), applicability (28%) and editorial independence (31%). According to the AGREE instrument, four guidelines can be strongly recommended, 18 with provisos and alterations while the remaining cannot be recommended for adaptation due to poor methodological quality.
Conclusion: Although existing HCC guidelines may accurately reflect agreed clinical practice, many guidelines lack proper methodological quality. Future guidelines should place more emphasis on these methodological shortcomings.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Conflict of interest statement
Conflict of interest statement: The authors indicated no potential conflicts of interest
Figures
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127: 2893–917. - PubMed
-
- Lang K, Danchenko N, Gondek K, Shah S, Thompson D. The burden of illness associated with hepatocellular carcinoma in the United States. J. Hepatol 2009; 50: 89–99. - PubMed
-
- Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Directions for A New Program. Washington DC: Institute of Medicine, National Academy Press, 1990. - PubMed
-
- Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J. Clin. Oncol 2001; 19: 2886–97. - PubMed
-
- Nast A, Spuls PH, Ormerod AD et al.A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: “AGREE-ing” on a common base for European evidence-based psoriasis treatment guidelines. J. Eur. Acad. Dermatol. Venereol 2009; 23: 782–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
